ATHENS, 01-02/04/2016 The kick-off meeting of the research program under the distinct title “EXANDAS” of the Marie Sklodowska Curie Actions (MSCA) programs was successfully organized on 1-2 April 2016. The specific program aims to exploit the aromatic plants’ by-products such as the Chios Mastic for the purpose of developing novel pharmaceutical products. The meeting took place [...]
NATIONAL CENTER FOR SCIENTIFIC RESEARCH “DEMOCRITOS”, 01-02/04/2016 IASIS PHARMA successfully participated in the 21st Hellenic Conference for Helicobacter Pylori and Other Infections of the Peptic System that took place at the National Center for Scientific Research “Democritos”, 1-2 April 2016 organized by the Hellenic Society for the Study of H pylori. Congress invitees included distinguished gastroenterologists [...]
THE MET HOTEL, THESSALONIKI, 23/03/2016 A scientific lecture under the title: “The role of Chios Mastic Gum on functional dyspepsia and helicobacter pylori. A novel Pharmaceutical approach” was successfully organized on Wednesday 23 March 2016 20:00 at the «THE ΜΕΤ HOTEL», in Thessaloniki. The event was addressed to GPs. The main speaker Dr. Hr. Zavos, specialized gastroenterologists-hepatologist, [...]
DIVANI CARAVEL HOTEL, ATHENS, 19/12/2015 ΙΑSIS PHARMA participated, as it consistently does every year, in the Annual Winter Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the DIVANI CARAVEL hotel, in Athens, 19 December 2015. ΙΑSIS PHARMA stand was visited by a high number of Dermatologists where two (2) of [...]
DIVANI CARAVEL HOTEL, ATHENS, 5-6/12/2015 ΙΑSIS PHARMA successfully participated in the 13th 2-Day Educational Workshop on Functional Diseases of the Peptic System that took place in Caravel Hotel Athens, 5-6 December 2015 organized by the Professional Association of Greek Gastroenterologists (EPEGE). Subjects covered during the workshop concerned basic research but also the clinical manifestations of the [...]
BRUSSELS, 10/11/2015 IASIS PHARMA proudly announces its participation in a program of H2020. The program Horizon 2020 is the financing framework of the EU for research and Innovation that will cover the period 2014-2020, with a budget of approximately 80 billion Euros. The program supports the strategy "Europe 2020" that promotes research and innovation as the [...]
IASIS PHARMA has a key role in the establishment of Chios Mastiha in Europe as well as globally as a unique herbal product with a wide range of beneficial but mainly therapeutic indications. in August 2015, European Medicines Association (EMA) unanimously decided to include Chios Mastiha in the category of traditional herbal medicines. Read more [...]
Our vision for a healthier world is always and absolutely connected with the environment. We respect Greek nature, learning from it and using the presents that kindly offers us. Thus, we are also able to create unique, natural compositions for the benefit of health. IASIS PHARMA contribution to the worldwide recognition of Chios Mastic as [...]
ΕLECTRA PALACE HOTEL, ATHENS, 06/10/15 For the video of the Press Conference given for the approval of Chios Mastic as Traditional Herbal Medicine by the European Medicines Agency visit the below link http://www.alithia.gr/tv/eidiseis/paroysiasi-farmakeytikis-mastihas-se-electra-palace-athinon-06102015-xios In the below links you can find the media publications on the Press Conference that took place on Tuesday, 6 October 2015 at [...]
DIVANI CARAVEL HOTEL, ATHENS, 26/09/2015 ΙΑSIS PHARMA participated, as it consistently does on annual basis, in the Annual Autumn Day Conference of the Hellenic Society of Dermatology and Venereology that took place at the DIVANI CARAVEL hotel, in Athens, 26 September 2015. ΙΑSIS PHARMA stand was visited by a high number of Dermatologists where three (3) [...]
